Regarding: ‘Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array’

por Pander, J, Gelderblom, H, van der Straaten, T, Punt, C J A, Guchelaar, H-J
Publicado 2010

Correlation between 5-fluorouracil metabolism and treatment response in two variants of C26 murine colon carcinoma

por Kamm, Y J L, Peters, G J, Hull, W E, Punt, C J A, Heerschap, A
Publicado 2003

UGT1A1(*)28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study

por Kweekel, D M, Gelderblom, H, Van der Straaten, T, Antonini, N F, Punt, C J A, Guchelaar, H-J
Publicado 2008

Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood

por Vries, T J de, Fourkour, A, Punt, C J A, Diepstra, H, Ruiter, D J, Muijen, G N P van
Publicado 1999

Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array

por Kweekel, D M, Antonini, N F, Nortier, J W R, Punt, C J A, Gelderblom, H, Guchelaar, H-J
Publicado 2009

Dendritic cell vaccination and immune monitoring

por Aarntzen, E. H. J. G., Figdor, C. G., Adema, G. J., Punt, C. J. A., de Vries, I. J. M.
Publicado 2008

Ethnic differences in colon cancer care in the Netherlands: a nationwide registry-based study

por Lamkaddem, M., Elferink, M. A. G., Seeleman, M. C., Dekker, E., Punt, C. J. A., Visser, O., Essink-Bot, M. L.
Publicado 2017

Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases

por Mekenkamp, L J M, Koopman, M, Teerenstra, S, van Krieken, J H J M, Mol, L, Nagtegaal, I D, Punt, C J A
Publicado 2010

Mitochondrial microsatellite instability in patients with metastatic colorectal cancer

por Venderbosch, S., van Vliet, S., Craenmehr, M. H. C., Simmer, F., de Haan, A. F. J., Punt, C. J. A., Koopman, M., Nagtegaal, I. D.
Publicado 2015

GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group

por Kweekel, D M, Koopman, M, Antonini, N F, Van der Straaten, T, Nortier, J W R, Gelderblom, H, Punt, C J A, Guchelaar, H-J
Publicado 2008

Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer

por Punt, C.J.A., Heinemann, V., Maughan, T., Cremolini, C., Van Cutsem, E., McDermott, R., Bodoky, G., André, T., Osterlund, P., Teske, A.J., Pfeiffer, P.
Publicado 2023

Assessment of Blood Hemodynamics by USPIO-Induced R(1) Changes in MRI of Murine Colon Carcinoma

por Gambarota, Giulio, van Laarhoven, H. W. M., Philippens, M., Peeters, W. J. M., Rijken, P., van der Kogel, A., Punt, C. J. A., Heerschap, A.
Publicado 2010

Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review

por Sloothaak, D A M, Mirck, B, Punt, C J A, Bemelman, W A, van der Bilt, J D W, D'Hoore, A, Tanis, P J
Publicado 2014

Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule

por Awada, A, Punt, C J A, Piccart, M J, Tellingen, O Van, Manen, L Van, Kerger, J, Groot, Y, Wanders, J, Verweij, J, Wagener, D J Th
Publicado 1999

Deficient mismatch repair system in patients with sporadic advanced colorectal cancer

por Koopman, M, Kortman, G A M, Mekenkamp, L, Ligtenberg, M J L, Hoogerbrugge, N, Antonini, N F, Punt, C J A, van Krieken, J H J M
Publicado 2009

Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours

por Gregorc, V, Santoro, A, Bennicelli, E, Punt, C J A, Citterio, G, Timmer-Bonte, J N H, Caligaris Cappio, F, Lambiase, A, Bordignon, C, van Herpen, C M L
Publicado 2009

ABC-Transporter Expression Does Not Correlate with Response to Irinotecan in Patients with Metastatic Colorectal Cancer

por Trumpi, K., Emmink, B.L., Prins, A.M., van Oijen, M.G.H., van Diest, P.J., Punt, C.J.A., Koopman, M., Kranenburg, O., Rinkes, I.H.M. Borel
Publicado 2015

Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation

por Tol, J., Cats, A., Mol, L., Koopman, M., Bos, M. M. E. M., van der Hoeven, J. J. M., Antonini, N. F., van Krieken, J. H. J. M., Punt, C. J. A.
Publicado 2008

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients

por Knijn, N, Mekenkamp, L J M, Klomp, M, Vink-Börger, M E, Tol, J, Teerenstra, S, Meijer, J W R, Tebar, M, Riemersma, S, van Krieken, J H J M, Punt, C J A, Nagtegaal, I D
Publicado 2011

Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR

por de Vries, T J, Fourkour, A, Punt, C J A, van de Locht, L T F, Wobbes, T, Bosch, S van den, Rooij, M J M de, Mensink, E J B M, Ruiter, D J, Muijen, G N P van
Publicado 1999